Streetbeat News

Equity Actions

DIS

Walt Disney Co (NYSE:DIS) is facing a proxy battle with activist investor Nelson Peltz, who criticizes the company's long-term stock performance and has nominated himself and former CFO Jay Rasulo to the board. Morgan Stanley's James Gorman, a new Disney board member, defends the company's direction, highlighting a 30% stock increase since the year's start and expressing confidence in the current management's future-focused strategy. Disney's annual shareholder meeting is set for April 3, where shareholders will vote on board nominations.

Portfolio Pulse from Adam Eckert

March 26, 2024 | 6:05 pm

CCL

NCLH

Mizuho analyst Ben Chaiken initiated coverage on Carnival Corp (NYSE:CCL) with a Buy rating and a $21 price target, citing fleet optimization and potential for explosive earnings growth. Carnival sold nearly 20% of its lower-margin fleet during the COVID shutdown, which is expected to significantly boost EBITDA/ALBD of the remaining fleet. The company's long-term earnings outlook suggests $6.8 billion in EBITDA by 2026, with a potential to generate $6 billion in FCF over the next three years. The analyst also notes a valuation discount to Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) and favorable future yield growth from new developments.

Portfolio Pulse from Shivani Kumaresan

March 26, 2024 | 5:58 pm

C

COIN

GL

GS

HOOD

MS

PYPL

SCHW

SQ

ZION

Today's whale activity in the Financials sector highlighted significant options trading across various stocks, indicating potential trading opportunities. Notable bearish sentiment was observed in call options for C, PYPL, MS, HOOD, GS, and SCHW, while bullish sentiment was seen in COIN, ZION, and GL put options. SQ's put option trade was neutral. These activities, based on the volume and open interest, suggest market participants are positioning for potential price movements in these stocks.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:35 pm

TRU

TransUnion (NYSE:TRU) has been analyzed by 11 analysts, showing a mix of bullish to indifferent sentiments. Recent ratings have shifted towards a more cautious stance, with no bullish ratings in the last 30 days. Analysts have raised their 12-month price targets for TRU, with an average target of $81.64, marking a 15.31% increase from the previous average of $70.80. The company's financial performance shows strong revenue growth and net margin, but challenges in ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

RRR

Red Rock Resorts (NASDAQ:RRR) has been evaluated by 12 analysts over the last three months, showing a diverse range of opinions. The average 12-month price target for RRR has increased to $59.75, up 12.52% from the previous $53.10. Analysts have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Red Rock Resorts's financial performance includes a notable revenue growth of 8.75% as of December 31, 2023, a net margin of 12.17%, an ROE of 38.54%, and an ROA of 1.44%, but with a high debt-to-equity ratio of 19.75.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

ELV

Elevance Health (NYSE:ELV) has seen a 15.56% decrease in short interest, now at 1.76 million shares or 0.76% of float, indicating a potential shift in market sentiment towards more bullish views. The current short interest is significantly lower than the peer group average of 4.27%, suggesting Elevance Health is performing well compared to its peers. This change in short interest could influence the stock's short-term movement.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

SFM

In the past three months, Sprouts Farmers Market (NASDAQ:SFM) received mixed analyst ratings, with a recent shift towards a more neutral stance. The average 12-month price target for SFM has increased to $56.8, reflecting a 12.7% rise from the previous target. Analysts from Evercore ISI Group and Goldman Sachs have raised their price targets, indicating a positive outlook on SFM's performance. Despite its smaller market capitalization, SFM has shown impressive revenue growth, a high net margin, and strong financial metrics such as ROE and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

NYCB

On CNBC, Jim Lebenthal announced that he has sold his holdings in New York Community Bancorp (NYCB).

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:52 pm

NARI

Inari Medical's stock is trading higher following the announcement that it will be included in the S&P SmallCap 600 index. This inclusion is often viewed positively as it reflects the company's growth and stability, and can lead to increased demand for the stock from funds that track the index.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:50 pm

BMY

On CNBC, Stephanie Link announced that she has sold her position in Bristol-Myers Squibb (BMY).

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 4:35 pm